Nubeqa 300mg tablet contains the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.

The Nubeqa uses include controlling the growth of prostate cancer cells and improving treatment outcomes when combined with other therapies. Patients should follow the prescribed Nubeqa dosage as advised by their doctor.

Like any cancer treatment, there can be Nubeqa side effects, so regular monitoring is essential. Patients should always consult their doctor before starting therapy.

For those looking into accessibility, the Nubeqa price and Nubeqa 300 mg price in India may vary depending on the pharmacy and region. Options to buy Nubeqa online are also available through certified platforms.

The Nubeqa manufacturer ensures strict quality standards to provide effective cancer treatment. Some patients may also compare Nubeqa vs enzalutamide to understand different treatment approaches.

Ongoing Nubeqa clinical trial data further supports its effectiveness and safety. Additionally, patients can explore options such as a Nubeqa coupon / discount or Nubeqa patient assistance programs to manage costs more effectively.

• Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment)
• Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.

Nubeqa 300mg works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells. 

Inform your doctor about any prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medicines may interact with Nubeqa 300mg tablet and can cause undesirable side effects.

• Keep Darolutamide out of sight and reach of children.
• This medication is to be stored at or below 30 °C.
• If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose.  Inform your physician about the missed dose. Do not take 2 doses at the same time.

Nubeqa tab 300 mg is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity. 

Nubeqa 300 mg side effects are unwanted symptoms caused by medicines. Even though all medicines cause nubeqa side effects, not everyone gets them. 

Common:

• Fatigue
• Rash
• Muscle pain
• Bone pain
• Pain in the arms and legs
• Broken bones

Serious:

• Chest pain
• Pain in arms, jaw, neck and back
• Lightheadedness or dizzy
• Shortness of breath
• Swelling of ankles and legs
• Seizures

• Inform your physician if you experience seizures, swelling in legs, ankles, or face, abdominal pain, shortness of breath, or chest pain after taking this medicine.

• Notify your physician if you are taking antibiotics, cholesterol medicines, or other prescribed medications.

• Nubeqa 300mg tablet is not indicated for children and adolescents under 18 years of age.

• Pregnant and breastfeeding women should not use this medicine, as it is prescribed for prostate cancer treatment.

1. Bayer (Pty) Ltd, Patient information leaflet, [Revised on 15th March 2022], [Accessed on 8th August 2022], https://www.bayer.com/sites/default/files/NUBEQA_EN_PIL.pdf#page=2 
2. Orion Corporation, Orion Pharma, Electronics Medicine Compendium (emc), [Revised on January 2021], [Accessed on 8th August 2022], https://www.medicines.org.uk/emc/files/pil.11324.pdf 
3.  Bayer HealthCare Pharmaceuticals Inc, U.S. Food and Drug Administration, [Revised on July 2019], [Accessed on 8th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf 
4. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: hormones and related agents, 12th edition, 2011, 1707 - 1709.